Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium (Consortium). The Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for arpraziquantel to treat one of the neglected tropical diseases, schistosomiasis, in preschool-aged chi
Nyong o calls for allocation of funds to deal with NTDs » Capital News capitalfm.co.ke - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalfm.co.ke Daily Mail and Mail on Sunday newspapers.
Arpraziquantel is the first investigational drug in regulatory phase amongst the different projects supported by the GHIT (Global Health Innovative Technology).
"While it is increasingly recognized that communities must be engaged throughout the full cycle of emergency preparedness, readiness, response and recovery, the question remains how community engagement can be ensured." Community engagement in emergencies is known to be critical, as empowering people to help themselves can save lives.